Cost-Effectiveness Of Rivaroxaban For The Treatment Of Pulmonary Embolism In Canada
Levac, B, Marrie, J, Chin, W, Hassan, F, Bamber, L, McLeod, E.J
Published in Value in health (01.05.2014)
Published in Value in health (01.05.2014)
Get full text
Journal Article
PCV51 Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Adult Patients With Non-Valvular Atrial Fibrillation with One or More Risk Factors – A UK Perspective
Asukai, Y, Duran, A, Lloyd, A, McLeod, E.J, Evers, T, Broughton, J
Published in Value in health (01.11.2012)
Published in Value in health (01.11.2012)
Get full text
Journal Article
PCV54 Economic Evaluation of Rivaroxaban in the Treatment of Deep Vein Thrombosis in Greece
Kourlaba, G, Maniadakis, N, Giannoukas, A, Katsamouris, A, Katsenis, K, Lazarides, M, Matsagas, M, Lowin, J, McLeod, E.J, Bamber, L
Published in Value in health (01.11.2012)
Published in Value in health (01.11.2012)
Get full text
Journal Article
PCV90 - Cost-Effectiveness Of Rivaroxaban For The Treatment Of Pulmonary Embolism In Canada
Levac, B., Marrie, J., Chin, W., Hassan, F., Bamber, L., McLeod, E.J.
Published in Value in health (01.05.2014)
Published in Value in health (01.05.2014)
Get full text
Journal Article